FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a generic buprenorphine and naloxone product from Lannett Company (ANDA205022) under an original application, for the treatment of opioid use disor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine and naloxone (BUPRENORPHINE AND NALOXONE)

Snippet

ORIG AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)